Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-06-21
2011-06-21
Li, Bao (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S093100, C435S326000
Reexamination Certificate
active
07964708
ABSTRACT:
The present invention provides antibodies that bind to the C-terminal region of TSG101. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections, including HIV and Ebola virus infection.
REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4741900 (1988-05-01), Alvarez et al.
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4980286 (1990-12-01), Morgan et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5225539 (1993-07-01), Winter
patent: 5514548 (1996-05-01), Krebber et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5624821 (1997-04-01), Winter et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5648237 (1997-07-01), Carter
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 5914112 (1999-06-01), Bednar et al.
patent: 5985615 (1999-11-01), Jakobovits et al.
patent: 6057098 (2000-05-01), Buechler et al.
patent: 6835816 (2004-12-01), Cohen et al.
patent: 7335468 (2008-02-01), Zavitz et al.
patent: 7427468 (2008-09-01), Li
patent: 2002/0177207 (2002-11-01), Sugiyama et al.
patent: WO 86/01533 (1986-03-01), None
patent: WO 87/02671 (1987-05-01), None
patent: WO 90/02809 (1990-03-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/06180 (1992-04-01), None
patent: WO 92/09690 (1992-06-01), None
patent: WO 92/15679 (1992-09-01), None
patent: WO 92/18619 (1992-10-01), None
patent: WO 92/20316 (1992-11-01), None
patent: WO 92/20791 (1992-11-01), None
patent: WO 92/22635 (1992-12-01), None
patent: WO 93/01288 (1993-01-01), None
patent: WO 93/14188 (1993-07-01), None
patent: WO 93/20221 (1993-10-01), None
patent: WO 94/08598 (1994-04-01), None
patent: WO 02/072790 (2002-09-01), None
patent: WO 2004/031209 (2004-04-01), None
patent: WO 2004/071462 (2004-04-01), None
Chua et al. J. Virol. 2007, vol. 81, No. 5, pp. 2459-2471.
Eastman et al. 2005, J. Bioloi. Chemistry vol. 280, No. 1, pp. 628-636.
Irie et al. J. Virol. 2004, vol. 78, No. 6, pp. 2657-2665.
Poillinos et al. The EMBO J. 2002, vol. 21, No. 10, pp. 2397-2406.
Zhong, et al. “Identification of Cellular TSG101 Protein in Multiple Human Breast Cancer Cell Lines”,Cancer Research, 57, pp. 4225-4228 (Oct. 1, 1997).
International Search Report dated Aug. 13, 2008, issued in International Appln. No. PCT/US07/84808.
Duan Roxanne
Goldblatt Michael
Kinch Michael
Li Limin
Kelber Steven B.
Li Bao
LandOfFree
Anti-TSG101 antibodies and their uses for treatment of viral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-TSG101 antibodies and their uses for treatment of viral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-TSG101 antibodies and their uses for treatment of viral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2698479